Publication | Closed Access

Low skeletal muscle mass is a predictive factor for chemotherapy dose-limiting toxicity in patients with locally advanced head and neck cancer

Chemotherapy Dose-limiting ToxicityNeck CancerPredictive FactorMedicinePathologyHead And Neck CancerMetronomic ChemotherapyCancer TreatmentNeck OncologyOncologyRadiation OncologyTreatment ResistanceCancer Research